Methotrexate and TNF inhibitors affect long-term immunogenicity to COVID-19 vaccination in patients with immune-mediated inflammatory disease
Authors:
- 1 April 2022
- journal article
- editorial
- Published by Elsevier in The Lancet Rheumatology
- Vol. 4 (6) , e384-e387
Abstract
No abstract availableFunding Information
- National Institute of Allergy and Infectious Diseases (AI082630, AI158617)
- Rheumatology Research Foundation
- National Institute of Diabetes and Digestive and Kidney Diseases (K23DK124570)
- Bloomberg Philanthropies
- Janssen Pharmaceutica
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR074500, T32-AR-069515)
- Crohn's and Colitis Foundation
- Rheumatology Research Foundation
- Pfizer
- BioFire Diagnostics
- National Institutes of Health
- Johnson and Johnson
This publication has 9 references indexed in Scilit:
- Large-Scale Study of Antibody Titer Decay following BNT162b2 mRNA Vaccine or SARS-CoV-2 InfectionVaccines, 2021
- Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 MonthsNew England Journal of Medicine, 2021
- Reduced antibody activity against SARS-CoV-2 B.1.617.2 delta virus in serum of mRNA-vaccinated individuals receiving tumor necrosis factor-α inhibitorsMed, 2021
- Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre studyAnnals of the Rheumatic Diseases, 2021
- Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory diseaseAnnals of the Rheumatic Diseases, 2021
- High antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with rheumatic and musculoskeletal diseasesAnnals of the Rheumatic Diseases, 2021
- Antibody Response to Hepatitis B Virus Vaccine is Impaired in Patients With Inflammatory Bowel Disease on Infliximab TherapyInflammatory Bowel Diseases, 2018
- Immunogenicity and Safety of Influenza Vaccine in Inflammatory Bowel Disease Patients Treated or not with Immunomodulators and/or Biologics: A Two-year Prospective StudyJournal of Crohn's and Colitis, 2015
- Effect of Methotrexate, Anti–Tumor Necrosis Factor α, and Rituximab on the Immune Response to Influenza and Pneumococcal Vaccines in Patients With Rheumatoid Arthritis: A Systematic Review and Meta‐AnalysisArthritis Care & Research, 2013